Patient-Reported Outcomes (PROs) from the Phase 2 TRANSCEND FL Study of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL)

被引：0

作者：

Cartron, Gillaume ^{[1
]}

Garcia-Sancho, Alejandro Martin ^{[2
]}

Reguera, Juan Luis ^{[3
]}

Dahiya, Saurabh ^{[4
]}

Guo, Shien ^{[5
]}

Shi, Ling ^{[5
]}

Eliason, Laurie ^{[6
]}

Kumar, Jinender ^{[6
]}

Farazi, Thalia ^{[7
]}

Fasan, Omotayo ^{[6
]}

Izutsu, Koji ^{[8
]}

机构：

[1] Montpellier Univ Hosp Ctr, Clin Hematol Dept, Montpellier, France

[2] Univ Salamanca, Hosp Univ Salamanca, IBSAL, CIBERONC, Salamanca, Spain

[3] Univ Seville, Dept Hematol, Univ Hosp Virgen Rocio IBIS, Seville, Spain

[4] Stanford Univ, Div Blood & Marrow Transplantat & Cellular Therap, Palo Alto, CA USA

[5] Evidera, Bethesda, MD USA

[6] Bristol Myers Squibb, Princeton, NJ USA

[7] Bristol Myers Squibb, San Francisco, CA USA

[8] Natl Canc Ctr, Tokyo, Japan

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180175

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] TRANSCEND FL: phase 2 study results of lisocabtagene maraleucel (liso-cel) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL)
Borchmann, Peter
Morschhauser, Franck
Dahiya, Saurabh
Palomba, M. Lia
Garcia-Sancho, Alejandro Martin
Reguera Ortega, Juan Luis
Kuruvilla, John
Jaeger, Ulrich
Cartron, Guillaume
Izutsu, Koji
Dreyling, Martin
Kahl, Brad
Ghesquieres, Herve
Ardeshna, Kirit
Goto, Hideki
Barbui, Anna Maria
Abramson, Jeremy S.
Fleury, Isabelle
Mielke, Stephan
Farazi, Thalia
Fasan, Omotayo
Lymp, James
Vedal, Min
Nishii, Rina
Avilion, Ariel
Papuga, Jessica
Nastoupil, Loretta J.
ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 142 - 143
[2] TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)
Nastoupil, Loretta J.
Dahiya, Saurabh
Palomba, M. Lia
Martin Garcia-Sancho, Alejandro
Reguera Ortega, Juan Luis
Kuruvilla, John
Jager, Ulrich
Cartron, Guillaume
Izutsu, Koji Izutsu
Dreyling, Martin
Kahl, Brad
Ghesquieres, Herve
Ardeshna, Kirit
Goto, Hideki
Barbui, Anna Maria
Abramson, Jeremy S.
Borchmann, Peter
Fleury, Isabelle
Mielke, Stephan
Farazi, Thalia
Fasan, Omotayo
Lymp, James
Vedal, Min
Nishii, Rina
Avilion, Ariel
Papuga, Jessica
Morschhauser, Frank
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S447 - S448
[3] Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study
Morschhauser, Franck
Dahiya, Saurabh
Palomba, M. Lia
Garcia-Sancho, Alejandro Martin
Ortega, Juan Luis Reguera
Kuruvilla, John
Jaeger, Ulrich
Cartron, Guillaume
Izutsu, Koji
Dreyling, Martin
Kahl, Brad
Ghesquieres, Herve
Ardeshna, Kirit
Goto, Hideki
Barbui, Anna Maria
Abramson, Jeremy S.
Borchmann, Peter
Fleury, Isabelle
Mielke, Stephan
Skarbnik, Alan
de Vos, Sven
Kamdar, Manali
Karmali, Reem
Viardot, Andreas
Farazi, Thalia
Fasan, Omotayo
Lymp, James
Vedal, Min
Nishii, Rina
Avilion, Ariel
Papuga, Jessica
Kumar, Jinender
Nastoupil, Loretta J.
NATURE MEDICINE, 2024, 30 (08) : 2199 - 2207
[4] Estimation of Postinfusion Resource Use and Total Costs of Care for Patients with R/R Follicular Lymphoma (FL) Receiving Lisocabtagene Maraleucel (liso-cel) in the TRANSCEND FL Study
Saunders, Ashley C.
Singh, Tavneet
Lee, Abraham
Farazi, Thalia
Fasan, Omotayo
Mirza, Sana
McGarvey, November
BLOOD, 2023, 142
[5] Impact of bridging therapy (BT) on lisocabtagene maraleucel (liso-cel) treatment in patients (pt) with R/R follicular lymphoma (FL)
Luis Reguera, Juan
Garcia-Sancho, Alejandro Martin
Kuruvilla, John
Izutsu, Koji
Maria Barbui, Anna
Peter, Borchmann
Mielke, Stephan
Lia Palomba, Maria
Cartron, Guillaume
Ghesquieres, Herve
Goto, Hideki
Varadarajan, Indumathy
Farazi, Thalia
Hui Kao, Grace Shih
Vedal, Min
Nishii, Rina
Papuga, Jessica
Morschhauser, Franck
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[6] Safety and Preliminary Efficacy in Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel (Liso-Cel) in TRANSCEND NHL 001
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 8 - 9
[7] TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as SecondLine Therapy in Patients with High-Risk Relapsed or Refractory Follicular Lymphoma
Morschhauser, Franck
Dahiya, Saurabh
Palomba, M. Lia
Garcia-Sancho, Alejandro Martin
Reguera, Juan Luis
Kuruvilla, John
Jaeger, Ulrich
Cartron, Guillaume
Izutsu, Koji
Dreyling, Martin
Kahl, Brad S.
Ghesquieres, Herve
Ardeshna, Kirit
Goto, Hideki
Barbui, Anna Maria
Abramson, Jeremy S.
Borchmann, Peter
Fleury, Isabelle
Mielke, Stephan
Skarbnik, Alan
de Vos, Sven
Kamdar, Manali
Karmali, Reem
Viardot, Andreas
Farazi, Thalia
Fasan, Omotayo
Lymp, James
Vedal, Min
Nishii, Rina
Avilion, Ariel
Papuga, Jessica
Nastoupil, Loretta J.
BLOOD, 2023, 142
[8] Health Care Resource Utilization (HCRU) and Cost of Management of Cytokine Release Syndrome (CRS) and Neurological Events (NEs) in Patients with R/R Follicular Lymphoma (FL) Receiving Lisocabtagene Maraleucel (liso-cel) in the TRANSCEND FL Study
Saunders, Ashley C.
Singh, Tavneet
Lee, Abraham
Farazi, Thalia
Fasan, Omotayo
Mirza, Sana
McGarvey, November
BLOOD, 2023, 142
[9] Safety and efficacy results from TRANSCEND NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) in relapsed/refractory large B-cell lymphoma
Abramson, J.
Palomba, M. L.
Gordon, L.
Lunning, M.
Wang, M.
Arnason, J.
Mehta, A.
Purev, E.
Maloney, D.
Andreadis, C.
Sehgal, A.
Solomon, S.
Ghosh, N.
Albertson, T.
Garcia, J.
Kostic, A.
Li, D.
Kim, Y.
Siddiqi, T.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 94 - 95
[10] Safety and Efficacy Results From Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (Liso-cel) In Relapsed/refractory Large B-Cell Lymphoma
Abramson, Jeremy
Palomba, M. Lia
Gordon, Leo
Lunning, Matthew
Wang, Michael
Arnason, Jon
Mehta, Amitkumar
Purev, Enkhtsetseg
Maloney, David
Andreadis, Charalambos
Sehgal, Alison
Solomon, Scott
Ghosh, Nilanjan
Albertson, Tina
Garcia, Jacob
Kostic, Ana
Li, Daniel
Kim, Yeonhee
Siddiqi, Tanya
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 43 - 44

← 1 2 3 4 5 →